OPEN END TURBO PUT WARRANT - AMGEN | Market Closed - Boerse Frankfurt Warrants 11:08:52 24/05/2024 pm IST | ||
| 1 EUR | +2.04% |
|
| Current month | -24.81% | ||
| 1 month | -25.37% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 1 | +2.04% |
| 23/24/23 | 0.98 | +5.38% |
| 22/24/22 | 0.93 | -1.06% |
| 21/24/21 | 0.94 | +1.08% |
| 20/24/20 | 0.93 | 0.00% |
Real-time Boerse Frankfurt Warrants
Last update May 24, 2024 at 11:08 pm IST
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UM0YEH |
| ISIN | DE000UM0YEH6 |
| Date issued | 04/01/2024 |
| Strike | 415 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 1.13 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.45 € |
|---|---|
| Lowest since issue | 0.84 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
